Biomarkers and surrogate endpoints: preferred definitions and conceptual framework
10.1067/mcp.2001.113989 · 2001
Urinalysis in Western culture: a brief history
10.1038/sj.ki.5002057 · 2007
Clinical chemistry since 1800: growth and development
10.1093/clinchem/48.1.186 · 2002
Unresolved referenced work
Kept as external metadata until matched
Lab-on-a-chip devices for global health: past studies and future opportunities
10.1039/b611455e · 2007
Cardiovascular disease in non-Western countries
10.1056/nejmp048024 · 2004
Microfluidics-based diagnostics of infectious diseases in the developing world
10.1038/nm.2408 · 2011
Unresolved referenced work
Kept as external metadata until matched
Cardiac troponin assays: a review of quantitative point-of-care devices and their efficacy in the diagnosis of myocardial infarction
10.1515/cclm-2014-0837 · 2015
High-sensitivity cardiac troponin t concentrations below the limit of detection to exclude acute myocardial infarction: a prospective evaluation
10.1373/clinchem.2014.231530 · 2015
A novel diagnostic protocol to identify patients suitable for discharge after a single high-sensitivity troponin
10.1136/heartjnl-2014-307288 · 2015
One-hour rule-in and rule-out of acute myocardial infarction using high-sensitivity cardiac troponin I
10.1016/j.amjmed.2015.01.046 · 2015
Serial changes in highly sensitive troponin I assay and early diagnosis of myocardial infarction
10.1001/jama.2011.1896 · 2011
High-sensitivity cardiac troponin I at presentation in patients with suspected acute coronary syndrome: a cohort study
10.1016/s0140-6736(15)00391-8 · 2015
Diagnostic performance of four point of care cardiac troponin I assays to rule in and rule out acute myocardial infarction
10.1016/j.clinbiochem.2013.06.026 · 2013
Mechanisms of thrombus formation
10.1056/nejmra0801082 · 2008
Evaluating the clinical usefulness of platelet function testing: considerations for the proper application and interpretation of performance measures
10.1160/th12-08-0608 · 2013
Global assays of hemostasis in the diagnostics of hypercoagulation and evaluation of thrombosis risk
10.1186/s12959-015-0038-0 · 2015
How do we manage cardiopulmonary bypass coagulopathy?
10.1111/trf.12751 · 2014
The coagulopathy of cardiopulmonary bypass
10.3109/10408363.2010.549291 · 2010
Defining the optimal activated clotting time during percutaneous coronary intervention: aggregate results from 6 randomized, controlled trials
10.1161/01.cir.103.7.961 · 2001
Standard- vs high-dose clopidogrel based on platelet function testing after percutaneous coronary intervention: the GRAVITAS randomized trial
10.1001/jama.2011.290 · 2011
Platelet reactivity and cardiovascular outcomes after percutaneous coronary intervention: a time-dependent analysis of the Gauging Responsiveness with a VerifyNow P2Y12 assay: Impact on Thrombosis and Safety (GRAVITAS) trial
10.1161/circulationaha.111.029165 · 2011
Should platelet function testing guide antiplatelet therapy for patients with coronary artery stenting or acute coronary syndromes?
10.1373/clinchem.2012.200881 · 2013
Circadian variation of acute myocardial infarction and the effect of low-dose aspirin in a randomized trial of physicians
10.1161/01.cir.82.3.897 · 1990
Circadian variation in the frequency of onset of acute myocardial infarction
10.1056/nejm198511213132103 · 1985
T2 magnetic resonance: a diagnostic platform for studying integrated hemostasis in whole blood—proof of concept
10.1373/clinchem.2014.223735 · 2014
Thrombin-induced platelet-fibrin clot strength: relation to high on-clopidogrel platelet reactivity, genotype, and post-percutaneous coronary intervention outcomes
10.1160/th13-08-0643 · 2014
Nanoparticles that sense thrombin activity as synthetic urinary biomarkers of thrombosis
10.1021/nn403550c · 2013
Point-of-care diagnostics for noncommunicable diseases using synthetic urinary biomarkers and paper microfluidics
10.1073/pnas.1314651111 · 2014
Disease detection by ultrasensitive quantification of microdosed synthetic urinary biomarkers
10.1021/ja505676h · 2014
Real-time clinical monitoring of biomolecules
10.1146/annurev.anchem.111808.073648 · 2013
Real-time, aptamer-based tracking of circulating therapeutic agents in living animals
10.1126/scitranslmed.3007095 · 2013
Universal noninvasive detection of solid organ transplant rejection
10.1073/pnas.1013924108 · 2011
Circulating cell-free DNA enables noninvasive diagnosis of heart transplant rejection
10.1126/scitranslmed.3007803 · 2014
Temporal response of the human virome to immunosuppression and antiviral therapy
10.1016/j.cell.2013.10.034 · 2013
Development of a blood-based gene expression algorithm for assessment of obstructive coronary artery disease in non-diabetic patients
10.1186/1755-8794-4-26 · 2011
Multicenter validation of the diagnostic accuracy of a blood-based gene expression test for assessing obstructive coronary artery disease in nondiabetic patients
10.7326/0003-4819-153-7-201010050-00005 · 2010
Exosomes and cardiac repair after myocardial infarction
10.1161/circresaha.114.300639 · 2014
Novel biomarkers for acute myocardial infarction: is microRNA the new kid on the block?
10.1373/clinchem.2013.215491 · 2014
